Market Updates

Cymbiotika Partners with Hundred Health on Biomarker Test Discount

Customers who purchase the brand's supplements can add a biomarker test, personalized protocol, and other Hundred Services at checkout for a fraction of the price.

Photo: Drobot Dean | Adobe Stock

Supplement brand Cymbiotika has announced a new partnership with Hundred Health, a personalized health and biomarker testing platform, to offer its customers a one-time discount on Hundred’s personalized biomarker test.

Customers who purchase a Cymbiotika supplement can access Hundred for a one-time fee of $49, a fraction of Hundred’s $199 retail value, which includes biomarker testing and a personalized 100-day protocol that integrates lab results, medical history, wearable data, and health goals.

Customers who purchase a qualifying Cymbiotika supplement will have the option to add the discounted Hundred biomarker test at checkout. Existing subscribers who have not yet redeemed the offer can also add it to an upcoming order through their account portal.

The offer includes a test panel of more than 100 biomarkers, the personalized hundred-day protocol of supplements, nutrition, and exercise, full access to the Hundred app, and the integration of wearables and medical records.

“For too long, wellness has meant giving everyone the same protocol and hoping it works. That era is over. Cymbiotika has always believed in real intention and real science behind every formula and this partnership is how we take that from generalized wellness to truly individualized wellness. With Hundred, our customers get a clear picture of what’s happening inside their bodies, so instead of guessing what they need, they know, and their routine is finally built around them, not the other way around,” said Chervin Jafarieh, co-founder and chief science officer of Cymbiotika.

“When Tyler [Smith, founder and CEO of Hundred] and I first got together to talk about this, it was never about revenue, it was always about joining forces to help as many people as possible. Cymbiotika gets our community the products; Hundred gets them the answers. Put together, that’s a much bigger mission than either of us could build alone,” said Shahab Elmi, co-founder and CEO of Cymbiotika.

“I spent years and an extraordinary amount of money assembling doctors, testing, and data just to understand what was happening inside my own body. Hundred was built so you shouldn’t need that kind of access to understand yours. Cymbiotika’s customers are already investing in their health every single day. This partnership means they get the same answers, without the years or the price tag, plus a real plan for what to do next. Your data isn’t the destination. Understanding it is,” said Smith.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters